Proteomic biomarkers of recovered heart function

Area of Science:

• Cardiology
• Proteomics
• Biomarker Discovery

Background:

• Chronic heart failure (CHF) is a widespread and costly condition affecting millions globally.
• Effective patient management requires reliable indicators of treatment response and functional recovery.

Purpose of the Study:

• To identify novel blood proteomic biomarker signatures indicative of recovered heart function in heart failure patients.
• To enable more effective patient management strategies for primary care and specialty physicians.

Main Methods:

• Utilized iTRAQ mass spectrometry on plasma from heart transplant patients and healthy controls.
• Identified proteins with differential levels pre- and post-transplant.
• Validated candidate biomarkers using multiple reaction monitoring mass spectrometry in a drug-treated heart failure cohort.

Main Results:

• Discovered an 18-protein signature differentiating heart failure from healthy states, with levels normalizing post-transplant.
• Validated a 17-protein panel with 93% sensitivity and 89% specificity in heart failure patients.
• The panel combined with NT-proBNP improved classification accuracy.

Conclusions:

• Identified potential blood biomarkers for assessing recovered heart function.
• These biomarkers could form the basis of an inexpensive diagnostic test for monitoring heart failure therapy response.
• Facilitates personalized, front-line management of heart failure patients.